Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, parallel-group study designed to evaluate the safety and activity
of IV MNTX in the treatment of Post-Operative Ileus (POI) in patients who underwent segmental
colectomies via laparotomy.
Phase:
Phase 2
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.